MEG3 and non-small cell lung carcinoma: Subsequently, the low MEG3 expression observed in NSCLC patients with an advanced pathological stage may be due to a deletion of the MEG3-DMR locus or could be due to the deletion of a transcription factor binding MEG3 promoter [150,151,152].